This recognition echoes the imperative across our industry to elevate first-time CEOs from underrepresented groups. To that end, the Termeer Foundation is dedicated to fostering new leadership in healthcare innovation by providing invaluable mentorship and networking opportunities – setting a platform for visionary leaders like Hanne to excel.

Hanne shares, “Bringing treatments to patients is ambitious, hard, and challenging work. As a Termeer Fellow, I can tap into a global network of incredible healthcare leaders and boost my personal growth as CEO, as I continue my mission to improve people’s lives with groundbreaking vaccines.”

Further underscoring the value of this mission is Eline van Beest, former recipient of a Termeer award in 2021. Eline, who previously founded and led sleep apnea company NightBalance to a successful exit to Philips in 2018, now leads Hybridize Therapeutics and contributes as a venture partner at Thuja Capital, board member at the Netherlands Academy of Engineering, and investment committee member at InvestNL. Eline’s journey through pioneering leadership roles exemplifies the powerful influence of nurturing top-tier first-time CEOs.

Thuja Capital takes immense pride in backing trailblazing leaders like Hanne and Eline. As staunch supporters of first-time female CEOs in European BioTech and MedTech, Thuja is committed to fostering a diverse leadership landscape that propels the industry forward with innovative solutions to the world’s most pressing healthcare problems.